SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹4,276 Cr | ₹4,567 Cr | ₹4,061 Cr | ₹3,647 Cr | ₹4,639 Cr |
What is the latest Contingent Liabilities ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹4,276 Cr |
| Mar2024 | ₹4,567 Cr |
| Mar2023 | ₹4,061 Cr |
| Mar2022 | ₹3,647 Cr |
| Mar2021 | ₹4,639 Cr |
How is Contingent Liabilities of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4,276 Cr | -6.38 | |
| Mar2024 | ₹4,567 Cr | 12.46 | |
| Mar2023 | ₹4,061 Cr | 11.36 | |
| Mar2022 | ₹3,647 Cr | -21.38 | |
| Mar2021 | ₹4,639 Cr | - | |
Compare Contingent Liabilities of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,697.5 Cr | 3.1% | 6.2% | 13.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,223.0 Cr | -1% | 3.3% | 14.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,928.0 Cr | -0% | 10% | 45.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,368.0 Cr | -0.6% | 3.3% | 16.4% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | -2% | -0.6% | -6.1% | Stock Analytics | |
| MANKIND PHARMA | ₹89,250.5 Cr | -3.7% | 3.8% | -5.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | 3.1% |
6.2% |
13.5% |
| SENSEX | -4.6% |
-7.5% |
6% |
You may also like the below Video Courses